We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RANI icon
7626
Rani Therapeutics
RANI
$88.8M
$11.4K ﹤0.01%
3,000
KF
7627
Korea Fund
KF
$251M
$11.4K ﹤0.01%
471
+321
+214% +$7.69K
EAPR icon
7628
Innovator Emerging Markets Power Buffer ETF April
EAPR
$98.5M
$11.3K ﹤0.01%
439
+34
+8% +$865
GARP
7629
iShares MSCI USA Quality GARP ETF
GARP
$2.75B
$11.3K ﹤0.01%
+218
New +$10.5K
GSST icon
7630
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.58B
$11.3K ﹤0.01%
224
-1,029
-82% -$51.7K
UUU icon
7631
Universal Safety Products Inc
UUU
$10.4M
$11.3K ﹤0.01%
7,009
+4,429
+172% +$7K
EJAN icon
7632
Innovator Emerging Markets Power Buffer ETF January
EJAN
$147M
$11.3K ﹤0.01%
+378
New +$11.1K
DVLT
7633
Datavault AI
DVLT
$248M
$11.3K ﹤0.01%
4,460
+2,932
+192% +$9.92K
USBC
7634
USBC Inc
USBC
$145M
$11.3K ﹤0.01%
687
+554
+417% +$14.1K
CPHC icon
7635
Canterbury Park Holding Corp
CPHC
$79.7M
$11.2K ﹤0.01%
515
+227
+79% +$5.18K
TORO icon
7636
Toro Corp
TORO
$181M
$11.2K ﹤0.01%
2,808
-1,282
-31% -$5.62K
MLEC icon
7637
Moolec Science
MLEC
$5.22M
$11.2K ﹤0.01%
68
+21
+45% +$3.98K
PYN
7638
DELISTED
PIMCO New York Municipal Income Fund III
PYN
$11.2K ﹤0.01%
1,903
-7,101
-79% -$41.3K
VOR icon
7639
Vor Biopharma
VOR
$1.2B
$11.2K ﹤0.01%
560
-1,359
-71% -$44K
KCGI.U
7640
DELISTED
Kensington Capital Acquisition Corp. V Units, each consisting of one Class A ordinary share and three-fourths of one redeemable warrant
KCGI.U
$11.1K ﹤0.01%
1,025
+1,000
+4,000% +$10.9K
PIK
7641
DELISTED
Kidpik Corp. Common Stock
PIK
$11.1K ﹤0.01%
+3,754
New +$13.5K
GBLI icon
7642
Global Indemnity Group
GBLI
$412M
$11.1K ﹤0.01%
357
+337
+1,685% +$10.6K
HIND
7643
Vyome Holdings
HIND
$15M
$11.1K ﹤0.01%
+10
New +$10.9K
SST icon
7644
System1
SST
$15.4M
$11K ﹤0.01%
725
-2,614
-78% -$44.1K
HUMAW icon
7645
Humacyte Inc Warrant
HUMAW
$1.09M
$11K ﹤0.01%
+7,925
New +$9.82K
SNFCA icon
7646
Security National Financial
SNFCA
$249M
$11K ﹤0.01%
1,595
-13,058
-89% -$83.1K
FENG
7647
Phoenix New Media
FENG
$18.3M
$11K ﹤0.01%
4,061
+4,050
+36,818% +$8.82K
SHLT
7648
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
$11K ﹤0.01%
2,159
+2,070
+2,326% +$10.9K
TLSI icon
7649
TriSalus Life Sciences
TLSI
$281M
$11K ﹤0.01%
1,988
+1,597
+408% +$13.5K
VIVS
7650
VivoSim Labs
VIVS
$1.26M
$10.9K ﹤0.01%
1,196
-63
-5% -$743

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.